Epsilon Healthcare

Epsilon Healthcare EBIT per Share

The EBIT per Share of Epsilon Healthcare (EPN.AX) as of Nov 3, 2026 is -0.01 AUD. In the previous year, EBIT per Share was -0.01 AUD — a change of -37.55% (higher).

EBIT per Share

-0.01AUD

YoY

-37.55%

Last updated:

EBIT per Share of Epsilon Healthcare is 2025 -0.01 AUD. EBIT per Share of Epsilon Healthcare was 2024 -0.01 AUD. It decreases by -37.55% higher compared to the previous year.

The Epsilon Healthcare EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-0.07 AUD
Jan 1, 2019
-0.07 AUD
Jan 1, 2020
-0.06 AUD
Jan 1, 2021
-0.04 AUD
Jan 1, 2022
-0.03 AUD
Jan 1, 2023
-0.01 AUD
Jan 1, 2024
-0.01 AUD
Jan 1, 2025
-0.01 AUD
The Epsilon Healthcare EBIT per Share history
YEAREBIT per ShareYoY
-0.01AUD-37.55%
-0.01AUD+24.63%
-0.01AUD-69.74%
-0.03AUD-30.93%
-0.04AUD-32.32%
-0.06AUD-15.43%
-0.07AUD-0.60%
-0.07AUD+179.73%
-0.02AUD-0.97%
-0.02AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Epsilon Healthcare Stock analysis

What does Epsilon Healthcare do? Epsilon Healthcare Ltd generates revenue through the manufacture and distribution of hydroponics equipment, materials, and nutrients, targeting commercial growers and hobbyists. The company also develops and delivers medical cannabis, operating a manufacturing facility in the Southern Hemisphere and providing advisory services for medicinal cannabis. Its subsidiaries, including Tetra Health clinic and Medimar Platform, offer end-to-end e-commerce solutions for nutraceuticals and cannabis, while Canna Clinics Pty Ltd and THC Pharma Pty Ltd deliver medical cannabis products. The firm's business segments focus on hydroponics and medicinal cannabis, serving both B2B and B2C markets through its branded platforms and subsidiaries. The company's products include hydroponics equipment, materials, nutrients, and medical cannabis, sold via its Medimar Platform e-commerce solution and physical locations like Tetra Health clinic. Subsidiaries such as Dragon Vision Limited and Metra Holdings Pty Ltd support operations, while Canndeo Pty Ltd and Canna Clinics Pty Ltd specialize in cannabis cultivation and delivery. The firm's advisory services for medicinal cannabis cater to healthcare providers and clinics, with the Tetra Health clinic serving as a direct sales channel for medical cannabis products. Epsilon Healthcare Ltd's revenue streams are derived from hydroponics equipment sales, medical cannabis distribution, and advisory services. The Medimar Platform serves as a primary channel for e-commerce transactions, while Tetra Health clinic and Canna Clinics Pty Ltd provide physical retail and medical services. The company's Southern Hemisphere manufacturing facility ensures supply chain control for medical cannabis, and its subsidiaries like THC Pharma Pty Ltd handle product development and delivery. The business model integrates manufacturing, distribution, and digital commerce to serve both commercial and medical cannabis markets. Epsilon Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Epsilon Healthcare stock

EBIT per Share of Epsilon Healthcare is -0.01 AUD in 2025.

EBIT per Share of Epsilon Healthcare changed from -0.01 AUD to -0.01 AUD, representing a -37.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Epsilon Healthcare since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Epsilon Healthcare

All Key Metrics — Epsilon Healthcare